From scarless fetal wounds to keloids: Molecular studies in wound healing

Wound Repair and Regeneration

Volumn 11, Issue 6, 2003, Pages 411-418

  Yang, George P ^a   Lim, Ivor J ^b   Phan, Toan Thang ^b   Lorenz, H Peter ^a   Longaker, Michael T ^a  

^a STANFORD UNIVERSITY   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CYTOKINE ANTIBODY; FIBROBLAST GROWTH FACTOR 2; FIBROMODULIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANGIOGENESIS; BONE DEVELOPMENT; CYTOLOGY; HUMAN; HYPOXIA; KELOID; MOLECULAR BIOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SCAR FORMATION; SIGNAL TRANSDUCTION; SKIN SCAR; SURGICAL TRAINING; UNITED STATES; VASCULARIZATION; WOUND; WOUND HEALING;

FETUS; FIBROBLASTS; HUMANS; INTERLEUKINS; KELOID; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 0345015320     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-475X.2003.11604.x     Document Type: Review

References (87)

1. Cass DL, Bullard KM, Sylvester KG, Yang EY, Longaker MT, Adzick NS. Wound size and gestational age modulate scar formation in fetal wound repair. J Pediatr Surg 1997;32:411-5.
2. Lorenz HP, Whitby DJ, Longaker MT, Adzick NS. Fetal wound healing The ontogeny of scar formation in the non-human primate. Ann Surg 1993;217:391-6.
3. Longaker MT, Whitby DJ, Adzick NS, Crombleholme TM, Langer JC, Duncan BW, Bradley SM, Stern R, Ferguson MW, Harrison MR. Studies in fetal wound healing, VI. Second and early third trimester fetal wounds demonstrate rapid collagen deposition without scar formation. J Pediatr Surg 1990;25:63-8. Discussion 68-9.
4. Beanes SR, Hu FY, Soo C, Dang CM, Urata. M, Ting K, Atkinson JB, Benhaim P, Hedrick MH, Lorenz HP. Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition. Plast Reconstr Surg 2002;109:160-70.
5. Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, Hedrick MH, Mackool RJ, Plaas A, Kim SJ, Longaker MT, Freymiller E, Ting K. Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 2000;157:423-33.
6. Frantz FW, Bettinger DA, Haynes JH, Johnson DE, Harvey KM, Dalton HP, Yager DR, Diegelmann RF, Cohen IK. Biology of fetal repair: the presence of bacteria in fetal wounds induces an adult-like healing response. J Pediatr Surg 1993;28:428-33. Discussion 433-4.
7. Jennings RW, Adzick NS, Longaker MT, Duncan BW, Scheuenstuhl H, Hunt TK. Ontogeny of fetal sheep polymorphonuclear leukocyte phagocytosis. J Pediatr Surg 1991;26:853-5.
8. Olutoye OO, Alaish SM, Carr ME Jr, Paik M, Yager DR, Cohen IK, Diegelmann RF. Aggregatory characteristics and expression of the collagen adhesion receptor in fetal porcine platelets. J Pediatr Surg 1995;30:1649-53.
9. Olutoye OO, Yager DR, Cohen IK, Diegelmann RF. Lower cytokine release by fetal porcine platelets: a possible explanation for reduced inflammation after fetal wounding. J Pediatr Surg 1996;31:91-5.
10. Olutoye OO, Barone EJ, Yager DR, Cohen IK, Diegelmann RF. Collagen induces cytokine release by fetal platelets: implications in scarless healing. J Pediatr Surg 1997;32:827-30.
11. Olutoye OO, Barone EJ, Yager DR, Uchida T, Cohen IK, Diegelmann RF. Hyaluronic acid inhibits fetal platelet function: implications in scarless healing. J Pediatr Surg 1997;32:1037-40.
12. Thomas BL, Krummel TM, Melang M, Cawthorn JW, Nelson JM, Cohen IK, Diegelmann RF. Collagen synthesis and type expression by fetal fibroblasts in vitro. Surg Forum 1988;39:642-3.
13. Clark RAF. Wound repair. Overview and general considerations. In: Clark RAF, editor. The molecular and cellular biology of wound repair. New York: Plenum Press, 1996:3-50.
14. Chen WY, Grant ME, Schor AM, Schor SL. Differences between adult and foetal fibroblasts in the regulation of hyaluronate synthesis: correlation with migratory activity. J Cell Sci 1989;94: 577-84.
15. Estes JM, Vande Berg JS, Adzick NS, MacGillivray TE, Desmouliere A, Gabbiani G. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994;56:173-81.
16. Roberts AB, Sporn MB. Transforming growth factor-β. In: Clark RAF, editor. The molecular and cellular biology of wound repair. New York: Plenum Press, 1996: 275-308.
17. Shah M, Foreman DM, Ferguson MW. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 1994;107:1137-57.
18. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci 1995;108:985-1002.
19. Soo C, Beanes SR, Dang C, Zhang X, Ting K. Fibromodulin, a TGF-β modulator, promotes scarless fetal repair. Surg Forum 2001;52: 578-81.
20. Dang C, Beanes SR, Soo C, Hedrick MH, Lorenz HP. A high ratio of TGF-β3 to TGF-β1 expression in wounds is associated with scarless repair. Wound Rep Reg 2001;9:153 [Abstract].
21. Hsu M, Peled ZM, Chin GS, Liu W, Longaker MT. Ontogeny of expression of transforming growth factor-beta 1 (TGF-beta 1), TGF-beta 3, and TGF-beta receptors I and II in fetal rat fibroblasts and skin. Plast Reconstr Surg 2001;107:1787-94. Discussion 1795-6.
22. Liechty KW, Adzick NS, Crombleholme TM. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 2000;12:671-6.
23. Liechty KW, Crombleholme TM, Cass DL, Martin B, Adzick NS. Diminished interleukin-8 (IL-8) production in the fetal wound healing response. J Surg Res 1998;77:80-4.
24. Ono I, Gunji H, Zhang JZ, Maruyama K, Kaneko F. A study of cytokines in burn blister fluid related to wound healing. Burns 1995; 21:352-5.
25. Gordon AD, Karmacharya J, Herlyn M, Crombleholme TM. Scarless wound healing induced by adenoviral-mediated overexpression of interleukin-10. Surg Forum 2001;52:568-9.
26. Whitby DJ, Ferguson MW. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991;147:207-15.
27. Haynes JH, Johnson DE, Mast BA, Diegelmann RF, Salzberg DA, Cohen IK, Krummel TM. Platelet-derived growth factor induces fetal wound fibrosis. J Pediatr Surg 1994;29:1405-8.
28. Dang CM, Beanes SR, Soo C, Ting K, Benhaim P, Hedrick MH, Lorenz HP. Decreased expression of fibroblast and keratinocyte growth factor isoforms and receptors during scarless repair. Plast Reconstr Surg 2003 May;111(6):1969-79.
29. Beanes SR, Dang C, Soo C, Lorenz HP. Differential expression of vascular endothelial growth factor in fetal wounds. Wound Rep Reg 2001;9:154 [Abstract].
30. Ravichandran KS. Signaling via Shc family adapter proteins. Oncogene 2001;20:6322-30.
31. Ikeda K, Wang LH, Torres R, Zhao H, Olaso E, Eng FJ, Labrador P, Klein R, Lovett D, Yancopoulos GD, Friedman SL, Lin HC. Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen. J Biol Chem 2002;277:19206-12.
32. Jung F, Haendeler J, Hoffmann J, Reissner A, Dembach E, Zeiher AM, Dimmeler S. Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein Shc in endothelial cells. Circ Res 2002;91:38-45.
33. Chin GS, Kim WJ, Lee TY, Liu W, Saadeh PB, Lee S, Levinson H, Gittes GK, Longaker MT. Differential expression of receptor tyrosine kinases and Shc in fetal and adult rat fibroblasts: toward defining scarless versus scarring fibroblast phenotypes. Plast Reconstr Surg 2000;105:972-9.
34. Stelnicki EJ, Komuves LG, Holmes D, Clavin W, Harrison MR, Adzick NS, Largman C. The human homeobox genes MSX-1, MSX-2, and MOX-1 are differentially expressed in the dermis and epidermis in fetal and adult skin. Differentiation 1997;62:33-41.
35. Stelnicki EJ, Arbeit J, Cass DL, Saner C, Harrison M, Largman C. Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless fetal wounds. J Invest Dermatol 1998;111:57-63.
36. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
37. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57.
38. Su H, Lu R, Kan YW. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci USA 2000;97:13801-6.
39. Ferrara N, Heinsohn H, Walder CE, Bunting S, Thomas GR. The regulation of blood vessel growth by vascular endothelial growth factor. Ann N Y Acad Sci 1995;752:246-56.
40. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N. VEGF is required for growth and survival in neonatal mice. Development 1999;126:1149-59.
41. Ailawadi M, Lee JM, Lee S, Hackett N, Crystal RG, Korst RJ. Adenovirus vector-mediated transfer of the vascular endothelial growth factor cDNA to healing abdominal fascia enhances vascularity and bursting strength in mice with normal and impaired wound healing. Surgery 2002;131:219-27.
42. Romano Di Peppe S, Mangoni A, Zambruno G, Spinetti G, Melillo G, Napolitano M, Capogrossi MC. Adenovirus-mediated VEGF (165) gene transfer enhances wound healing by promoting angiogenesis in CD1 diabetic mice. Gene Ther 2002;9:1271-7.
43. Zelzer E, McLean W, Ng YS, Fukai N, Reginato AM, Lovejoy S, D'Amore PA, Olsen BR. Skeletal defects in VEGF (120/120) mice reveal multiple roles for VEGF in skeletogenesis. Development 2002;129:1893-904.
44. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5:623-8.
45. Street J, Bao M, deGuzman L, Bunting S, Peale FV Jr, Ferrara N, Steinmetz H, Hoeffel J, Cleland JL, Daugherty A, van Bruggen N, Redmond HP, Carano RA, Filvaroff EH. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 2002;99:9656-61.
46. Hidai C, Zupancic T, Penta K, Mikhail A, Kawana M, Quertermous EE, Aoka Y, Fukagawa M, Matsui Y, Platika D, Auerbach R, Hogan BL, Snodgrass R, Quertermous T. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Genes Dev 1998;12: 21-33.
47. Penta K, Varner JA, Liaw L, Hidai C, Schatzman R, Quertermous T. Dell induces integrin signaling and angiogenesis by ligation of alphaVbeta3. J Biol Chem 1999;274:11101-9.
48. Lau LF, Lam SC. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999;248:44-57.
49. Perbal B. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 2001;54:57-79.
50. Fassett JT, Nilsen-Hamilton M. Mrp3, a mitogen-regulated protein/proliferin gene expressed in wound healing and in hair follicles. Endocrinology 2001;142:2129-37.
51. Toft DJ, Rosenberg SB, Bergers G, Volpert O, Linzer DI. Reactivation of proliferin gene expression is associated with increased angiogenesis in a cell culture model of fibrosarcoma tumor progression. Proc Natl Acad Sci USA 2001;98:13055-9.
52. Linzer DI, Nathans D. Nucleotide sequence of a growth-related mRNA encoding a member of the prolactin-growth hormone family. Proc Natl Acad Sci USA 1984;81:4255-9.
53. Linzer DI, Nathans D. A new member of the prolactin-growth hormone gene family expressed in mouse placenta. EMBO J 1985;4:1419-23.
54. Linzer DI, Lee SJ, Ogren L, Talamantes F, Nathans D. Identification of proliferin mRNA and protein in mouse placenta. Proc Natl Acad Sci USA 1985;82:4356-9.
55. Bloch W, Huggel K, Sasald T, Grose R, Bugnon P, Addicks K, Timpl R, Werner S. The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing. FASEB J 2000;14:2373-6.
56. Streit M, Velasco P, Riccardi L, Spencer L, Brown LF, Janes L, Lange-Asschenfeldt B, Yano K, Hawighorst T, Iruela-Arispe L, Detmar M. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice. EMBO J 2000;19:3272-82.
57. Klein SA, Bond SJ, Gupta SC, Yacoub OA, Anderson GL. Angiogenesis inhibitor TNP-470 inhibits murine cutaneous wound healing. J Surg Res 1999;82:268-74.
58. Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001;29: 560-4.
59. Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995;92:768-72.
60. Heeschen C, Jang JJ, Weis M, Pathak A, Kaji S, Hu RS, Tsao PS, Johnson FL, Cooke JP. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-9.
61. Jacobi J, Jang JJ, Sundram U, Dayoub H, Fajardo LF, Cooke JP. Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol 2002;161:97-104.
62. Yang X, Castilla LH, Xu X, Li C, Gotay J, Weinstein M, Liu PP, Deng CX. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 1999;126:1571-80.
63. Darby IA, Bisucci T, Raghoenath S, Olsson J, Muscat GE, Koopman P. Sox18 is transiently expressed during angiogenesis in granulation tissue of skin wounds with an identical expression pattern to Flk-1 mRNA. Lab Invest 2001;81:937-43.
64. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999;104:1435-58.
65. Ramakrishnan KM, Thomas KP, Sundararajan CR. Study of 1,000 patients with keloids in South India. Plast Reconstr Surg 1974;53:276-80.
66. Cohen IK, McCoy BJ, Mohanakumar T, Diegelmann RF. Immunoglobulin, complement, and histocompatibility antigen studies in keloid patients. Plast Reconstr Surg 1979;63:689-95.
67. Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc 1975;67:428-32.
68. Laurentaci G, Dioguardi D. HLA antigens in keloids and hypertrophic scars. Arch Dermatol 1977;113:1726.
69. Kischer CW, Thies AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 1982;13:819-24.
70. Abergel RP, Pizzurro, D, Meeker CA, Lask G, Matsuoka LY, Minor RR, Chu ML, Uitto J. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985;84:384-90.
71. Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, Chu ML, Uitto J. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. J Invest Dermatol 1991;97:240-8.
72. Polo M, Smith PD, Kim YJ, Wang X, Ko F, Robson MC. Effect of TGF-beta2 on proliferative scar fibroblast cell kinetics. Ann Plast Surg 1999;43:185-90.
73. Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, Fivenson DP. p53 and apoptosis alterations in keloids and keloid fibroblasts. Wound Rep Reg 1998;6:28-37.
74. Appleton I, Brown NJ, Willoughby DA. Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 1996;149:1441-7.
75. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT. Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999;43:179-84.
76. McCauley RL, Chopra V, Li YY, Hemdon DN, Robson MC. Altered cytokine production in black patients with keloids. J Clin Immunol 1992;12:300-8.
77. Tan EM, Peltonen J. Endothelial cell growth factor and heparin regulate collagen gene expression in keloid fibroblasts. Biochem J 1991;278:863-9.
78. Tan EM, Rouda S, Greenbaum SS, Moore JH Jr, Fox JW 4th, Sollberg S. Acidic and basic fibroblast growth factors down-regulate collagen gene expression in keloid fibroblasts. Am J Pathol 1993;142: 463-70.
79. Yoshimoto H, Ishihara H, Ohtsuru A, Akino K, Murakami R, Kuroda H, Namba H, Ito M, Fujii T, Yamashita S. Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 1999;154:883-9.
80. Smola H, Thiekotter G, Fusenig NE. Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 1993;122:417-29.
81. Maas-Szabowski N, Shimotoyodome A, Fusenig NE. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 1999;112:1843-53.
82. Garner WL. Epidermal regulation of dermal fibroblast activity. Plast Reconstr Surg 1998;102:135-9.
83. Katz AB, Taichman LB. Epidermis as a secretory tissue: an in vitro tissue model to study keratinocyte secretion. J Invest Dermatol 1994;102:55-60.
84. Lim IJ, Phan TT, Song C, Tan WT, Longaker MT. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg 2001;107:797-808.
85. Phan TT, Lim IJ, Bay BH, Qi R, Huynh HT, Lee ST, Longaker MT. Differences in collagen production between normal and keloid-derived fibroblasts in serum-media co-culture with keloid-derived keratinocytes. J Dermatol Sci 2002;29:26-34.
86. Lim IJ, Phan TT, Bay BH, Qi R, Huynh H, Tan WT, Lee ST, Longaker MT. Fibroblasts cocultured with keloid keratinocytes: normal fibroblasts secrete collagen in a keloidlike manner. Am J Physiol Cell Physiol 2002;283:C212-22.
87. Phan TT, Lim IJ, Bay BH, Qi R, Longaker MT, Lee ST, Huynh H. Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am J Physiol Cell Physiol 2003 Apr, 284(4):C860-9.